Colorado Senate Bill 31
Session 2026A
Use of Prescription Product with Controlled Substance
Introduced
Introduced in House on Feb 25, 2026
Sponsors
4 Sponsors
W. Lindstedt
J. Rich
S. Camacho
M. Soper
First Action
Jan 22, 2026
Latest Action
Feb 25, 2026
Origin Chamber
Senate
Type
Bill
Bill Number
31
State
Colorado
Session
2026A
J. Rich
grade
Sponsor
M. Soper
grade
Sponsor
S. Camacho
grade
Sponsor
W. Lindstedt
grade
Sponsor
J. Bridges
Cosponsor
J. Coleman
Cosponsor
N. Hinrichsen
Cosponsor
Motion Text
Refer Senate Bill 26-031, as amended, to the Committee of the Whole.
Senate Roll Call Votes
Excused
Yes
Yes
Yes
Yes
Summary
The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is:Approved for prescription use by the United States food and drug administration; andDesignated or rescheduled by the United States drug enforcement agency (DEA).The exemption applies upon the DEA's designation or rescheduling.The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.(Note: This summary applies to this bill as introduced.)
Committee Report for Health & Human Services on 02/12/2026
Sort by most recent
02/25/2026
House
Introduced In House - Assigned to Health & Human Services
02/24/2026
Senate
Senate Third Reading Passed - No Amendments
02/23/2026
Senate
Senate Second Reading Passed with Amendments - Committee, Floor
02/18/2026
Senate
Senate Second Reading Laid Over to 02/23/2026 - No Amendments
02/12/2026
Senate
Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
02/04/2026
Senate
Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only
01/22/2026
Senate
Introduced In Senate - Assigned to Health & Human Services
Sources
CO Legislature
Open States
Record Created
Jan 23, 2026 12:49:36 AM
Record Updated
Feb 26, 2026 1:07:56 AM